# A Phase I Trial of HS-10241 in Solid Tumors

> **NCT02759640** · PHASE1 · COMPLETED · sponsor: **Atridia Pty Ltd.** · enrollment: 7 (actual)

## Conditions studied

- Neoplasm
- Solid Tumors

## Interventions

- **DRUG:** HS-10241

## Key facts

- **NCT ID:** NCT02759640
- **Lead sponsor:** Atridia Pty Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2018-03
- **Final completion:** 2018-05
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2022-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02759640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02759640, "A Phase I Trial of HS-10241 in Solid Tumors". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT02759640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*